The third episode of the ISNKDIGO Webinar Series looks at What’s New in the Management and Treatment of Glomerulonephritis: A look at IgAN and MN.

There are exciting research developments that promise to fundamentally impact the treatment of IgA nephropathy. This includes results of new clinical trials, as well as innovative trials of novel approaches to IgAN treatment. During this webinar, the results of clinical trials of new supportive and immunosuppressive treatments is reviewed; treatment challenges and unmet clinical needs are highlighted. There is also be an overview of how new understanding of the pathophysiology of IgAN has broadened opportunities for trials of novel targeted therapies for this important global cause of kidney disease.

This webinar series was developed with support from Novartis.